Elevance Health's recent FQ3 2025 results showed a double beat, with revenue up 12% year-over-year. Read why ELV stock is a Buy.

Jack Hough talks to Steve Quirk, chief brokerage officer at Robinhood, about trends in retail investing.

The Dow, S&P 500, and Nasdaq are all set to snap their five-day win streaks today, as techs tocks struggle once more ...

S&P 500 faces high valuations due to AI tech giants. Discover why sector rotation and diversification may offer better ...

While several retail favorites and high-growth technology stocks are struggling to find holiday cheer this year, the story in ...

RBC Wealth Management technical strategist Rob Sluymer takes a look at popular trades in tech and international stocks and ...

Small-cap stocks have frustrated investors for years, but with the macroeconomic environment shifting, this sector could be ...